Genmark Diagnostics

Genmark Diagnostics Net Debt per Share

Delisted

The Net Debt per Share of Genmark Diagnostics (GNMK) as of Oct 13, 2026 is -0.79 USD. In the previous year, Net Debt per Share was 0.22 USD — a change of -462.49% (lower).

Net Debt per Share

-0.79USD

YoY

-462.49%

Last updated:

Net Debt per Share of Genmark Diagnostics is 2020 -0.79 USD. Net Debt per Share of Genmark Diagnostics was 2019 0.22 USD. It decreases by -462.49% lower compared to the previous year.

The Genmark Diagnostics Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2014
0.00 USD
Jan 1, 2015
-0.49 USD
Jan 1, 2016
-0.30 USD
Jan 1, 2017
-0.61 USD
Jan 1, 2018
-0.13 USD
Jan 1, 2019
0.22 USD
Jan 1, 2020
-0.79 USD
The Genmark Diagnostics Net Debt per Share history
YEARNet Debt per ShareYoY
-0.79USD-462.49%
0.22USD-271.87%
-0.13USD-79.24%
-0.61USD+102.12%
-0.30USD-38.86%
-0.49USD—
0.00USD—
Access this data via the Eulerpool API

Genmark Diagnostics Stock analysis

What does Genmark Diagnostics do? The company Genmark Diagnostics was founded in 1999 in California, USA. Its goal is to develop and produce diagnostic and testing solutions for the medical and biotechnology industries, with a focus on microfluidic technology. The company offers comprehensive services from the development of diagnostic and testing solutions to the production of devices and systems. Its main business areas are molecular diagnostics, laboratory test automation, and genomics. Genmark Diagnostics provides a variety of test solutions for diseases in the field of molecular diagnostics, as well as automation platforms for laboratory testing and products for genomic analysis. The company's products, such as the ePlex® system, aim to improve the accuracy and speed of medical diagnostics. Genmark Diagnostics is headquartered in Carlsbad, California, USA and has international branches. Its mission is to enhance the accuracy and speed of medical diagnostics worldwide through innovative devices and systems. Genmark Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmark Diagnostics stock

Net Debt per Share of Genmark Diagnostics is -0.79 USD in 2020.

Net Debt per Share of Genmark Diagnostics changed from 0.22 USD to -0.79 USD, representing a -462.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share Genmark Diagnostics since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

Other — Genmark Diagnostics

All Key Metrics — Genmark Diagnostics